Trials / Completed
CompletedNCT00782405
Effect of Quetiapine XR on Sleep in Patients With Major Depression, as Compared With Mirtazapine
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Technical University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the effects of (a) quetiapine XR and (b) mirtazapine on sleep when given as an antidepressant (monotherapy). We hypothesize that (a) quetiapine XR has an immediate and lasting positive effect on sleep in depressed patients which does not differ from the impact of mirtazapine on sleep in this group of patients; (b) in the context of a secondary objective, we expect an antidepressant effect of quetiapine XR which is equivalent to that of mirtazapine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | quetiapine | XR, 150-300mg |
| DRUG | mirtazapine | 30-45 mg |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2011-04-01
- First posted
- 2008-10-31
- Last updated
- 2011-04-19
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00782405. Inclusion in this directory is not an endorsement.